Suppr超能文献

过氧化物酶体增殖物激活受体γ(PPARγ)在尿路梗阻期间促进尿路上皮重塑。

PPARγ Promotes Urothelial Remodeling During Urinary Tract Obstruction.

作者信息

Jackson Ashley, El-Harakeh Mohammad, Rodriguez-Tirado Felipe, Miehls Alexa, Hardman Andrew, Camara Oumoulkhairy, Grounds Kelly, Tocaj Glenis, Kercsmar Macie, Li Birong, Wang Xin, Becknell Brian

机构信息

Nationwide Children's Hospital.

The Abigail Wexner Research Institute at Nationwide Children's hospital.

出版信息

Res Sq. 2024 Dec 2:rs.3.rs-5234950. doi: 10.21203/rs.3.rs-5234950/v1.

Abstract

Urinary tract obstruction (UTO) is a common cause of kidney injury that can result in chronic kidney disease and end-stage renal disease. Heterogeneity in the extent of obstructive renal damage in humans with UTO implies the existence of unknown mechanisms that protect against or accelerate kidney injury. Prior studies show that congenital and acquired UTO initiate a conserved, protective program of renal urothelium remodeling that culminates in expansion of uroplakin (UPK)+ cells to promote renal structural integrity. However, the cellular and molecular mechanisms that regulate UPK expression in the renal urothelium are unknown. Peroxisome proliferator-activated receptor γ (PPARγ) drives urothelial differentiation and UPK expression in other tissues but has not been investigated in the renal urothelium. Here, we demonstrate that activation of PPARγ in UPK+ cells is critical for UTO-induced renal urothelium remodeling. Conditional deletion of PPARγ perturbs UPK expression and accelerates parenchymal thinning during UTO, while conditional activation of PPARγ increases UPK expression and results in parenchymal preservation. This study underscores the significance of renal urothelium during UTO and shows that UTO-induced renal urothelial remodeling is achieved through activation of PPARγ. These findings form the foundation for future studies that will determine the therapeutic utility of PPARγ agonists during congenital and acquired UTO.

摘要

尿路梗阻(UTO)是肾损伤的常见原因,可导致慢性肾脏病和终末期肾病。UTO患者梗阻性肾损伤程度的异质性意味着存在未知的保护或加速肾损伤的机制。先前的研究表明,先天性和后天性UTO启动了一个保守的、保护性的肾尿路上皮重塑程序,最终导致尿血小板溶素(UPK)+细胞扩张,以促进肾脏结构完整性。然而,调节肾尿路上皮中UPK表达的细胞和分子机制尚不清楚。过氧化物酶体增殖物激活受体γ(PPARγ)在其他组织中驱动尿路上皮分化和UPK表达,但尚未在肾尿路上皮中进行研究。在这里,我们证明PPARγ在UPK+细胞中的激活对于UTO诱导的肾尿路上皮重塑至关重要。PPARγ的条件性缺失会扰乱UPK表达,并在UTO期间加速实质变薄,而PPARγ的条件性激活会增加UPK表达并导致实质保留。这项研究强调了肾尿路上皮在UTO期间的重要性,并表明UTO诱导的肾尿路上皮重塑是通过PPARγ的激活实现的。这些发现为未来确定PPARγ激动剂在先天性和后天性UTO中的治疗效用的研究奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5fc/11643314/d71f16ee4852/nihpp-rs5234950v1-f0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验